Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
- Alternative title
-
Die Rolle Antikörper-vermittelter Inhibierung von MHC class I chain-related protein A „shedding“ in der Tumortherapie
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2023
- Keyword
-
Rezeptor
Genexpression
Natürliche Killerzelle
Maus
B-Lymphozyt
Immunsystem
- Event
-
Veröffentlichung
- (where)
-
Darmstadt
- (who)
-
Universitäts- und Landesbibliothek
- (when)
-
2023
- Creator
- Contributor
- DOI
-
10.26083/tuprints-00024482
- URN
-
urn:nbn:de:tuda-tuprints-244826
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:43 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liptáková, Veronika
- Kolmar, Harald
- Steinle, Alexander
- Universitäts- und Landesbibliothek
Time of origin
- 2023
Other Objects (12)
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Biopolymeric scaffold to achieve high drug-to-antibody ratios using site specific conjugation strategies
Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Characterization of soy protein hydrolysates and influence of its iron content on monoclonal antibody production by a murine hybridoma cell line
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Biopolymeric scaffold to achieve high drug-to-antibody ratios using site specific conjugation strategies
Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Characterization of soy protein hydrolysates and influence of its iron content on monoclonal antibody production by a murine hybridoma cell line
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Biopolymeric scaffold to achieve high drug-to-antibody ratios using site specific conjugation strategies
Novel technologies for antibody hit discovery and engineering of antibody-like proteins with therapeutic relevance
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Characterization of soy protein hydrolysates and influence of its iron content on monoclonal antibody production by a murine hybridoma cell line
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
Conditional activation of an anti-IgM antibody-drug conjugate for precise B cell lymphoma targeting
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation